Cancer Specialists Wield Breakthrough Courses in Treatment for Mesothelioma, despite the Fact that Prognosis Looks Bleak
Doctors who specialize in cancer treatment choose what type of treatment to go with to each patient. There are numerous options. There is no regular treatment course for pleural mesothelioma cancer sufferers. This is due to the cancers high mortality rate, rareness, low treatment success rate, and small number of studies to provide meaningful statistics.
The prospects for mesothelioma patients have been grim, but doctors have recently made progress. Treatments for cancer are traditionally surgery (taking out the tumor and surrounding tissue), chemotherapy (poisoning cancerous cells) and radiation (killing cancer cells with radiation) There are problems with all three. Traditional radiation therapy has not worked well with mesothelioma patients. In hopes to lessen damage to healthy tissue, researches are studying ways to aim radiation right at the tumor.
The mesothelial tissue around the tumor is removed by surgery. It is a grueling surgery with unknown benefits to patients. Most chemotherapy medication that work on other cancers typically do not work on mesothelioma, and combinations of chemotherapy agents have been tried, but without much success. As with radiation, research is going toward controlling the physical location of the treatment with emphasis on the pleural cavity.
The high-mortality rate for mesothelioma patients means cutting-edge techniques for cancer are tried out. These include biologic therapy such as the agent interleukin 2 and anti-angiogenesis drugs such as thalidomide. A new drug that has shown results in improving survival is pemetrexed (brand name Alimta).
Before acting, oncologists review the stage of mesothelioma, position of the tumor, and age and health status of the patient. Two exotic ways of attacking mesothelioma are gene therapy and photodynamic therapy. Mesothelioma patients sometimes become involved in clinical trials in this area, and see benefits.
